Ammar Sabilarrohman

The State of the Biopharma Workforce: Navigating a Period of Strategic Contraction

• Treatment Innovations

The State of the Biopharma Workforce: Navigating a Period of Strategic Contraction

Ammar Sabilarrohman May 12, 2026 0

The global biopharmaceutical sector, a pillar of innovation and economic stability, is currently traversing a complex period...

Read More Read more about The State of the Biopharma Workforce: Navigating a Period of Strategic Contraction

From the Court to the Clinic: A Journey of Resilience, Community, and Early Detection

• Survivorship and Post-Treatment

From the Court to the Clinic: A Journey of Resilience, Community, and Early Detection

Ammar Sabilarrohman May 11, 2026 0

By Tori Ashman | November 12, 2025 When Tori Ashman signed up for Mamanet—a recreational sports league...

Read More Read more about From the Court to the Clinic: A Journey of Resilience, Community, and Early Detection

Building Bridges to Universal Health: A New Global Era for Migrant and Refugee Care

• Breast Cancer Prevention and Lifestyle

Building Bridges to Universal Health: A New Global Era for Migrant and Refugee Care

Ammar Sabilarrohman May 10, 2026 0

In a pivotal shift for global public health, the World Health Organization (WHO) has unveiled a comprehensive...

Read More Read more about Building Bridges to Universal Health: A New Global Era for Migrant and Refugee Care

The Weight of Evidence: Unraveling the Complex Link Between Obesity and Rising Cancer Rates

• Clinical Oncology Education

The Weight of Evidence: Unraveling the Complex Link Between Obesity and Rising Cancer Rates

Ammar Sabilarrohman May 10, 2026 0

In recent years, the oncology community has been confronted with a sobering, paradoxical trend: while traditional behavioral...

Read More Read more about The Weight of Evidence: Unraveling the Complex Link Between Obesity and Rising Cancer Rates

Real-World Success: UK Study Validates Chemoimmunotherapy for Advanced Oesophago-Gastric Cancers

• Clinical Oncology Education

Real-World Success: UK Study Validates Chemoimmunotherapy for Advanced Oesophago-Gastric Cancers

Ammar Sabilarrohman May 9, 2026 0

A new multi-centre study from the UK offers promising real-world evidence for patients battling advanced oesophago-gastric (OG)...

Read More Read more about Real-World Success: UK Study Validates Chemoimmunotherapy for Advanced Oesophago-Gastric Cancers

Beyond the Operating Room: How Food Deserts Impact Breast Reconstruction Outcomes

• Breast Cancer Surgery and Reconstruction

Beyond the Operating Room: How Food Deserts Impact Breast Reconstruction Outcomes

Ammar Sabilarrohman May 9, 2026 0

For thousands of women undergoing mastectomy, breast reconstruction represents a vital step toward physical and psychological recovery....

Read More Read more about Beyond the Operating Room: How Food Deserts Impact Breast Reconstruction Outcomes

The Invisible Standard: How Nose Attractiveness Redefines Facial Harmony and Perception

• Breast Cancer Surgery and Reconstruction

The Invisible Standard: How Nose Attractiveness Redefines Facial Harmony and Perception

Ammar Sabilarrohman May 9, 2026 0

In the meticulous world of plastic surgery, the nose has long been considered the centerpiece of the...

Read More Read more about The Invisible Standard: How Nose Attractiveness Redefines Facial Harmony and Perception

Rivanna’s Accuro XV Secures FDA Clearance: A New Frontier in Point-of-Care Musculoskeletal Imaging

• Treatment Innovations

Rivanna’s Accuro XV Secures FDA Clearance: A New Frontier in Point-of-Care Musculoskeletal Imaging

Ammar Sabilarrohman May 8, 2026 0

In a major milestone for point-of-care diagnostics, Virginia-based medical technology innovator Rivanna has received US Food and...

Read More Read more about Rivanna’s Accuro XV Secures FDA Clearance: A New Frontier in Point-of-Care Musculoskeletal Imaging

The GLP-1 Paradox: Pharmaceutical R&D Productivity Rebounds, But at What Cost?

• Chemotherapy and Targeted Therapy

The GLP-1 Paradox: Pharmaceutical R&D Productivity Rebounds, But at What Cost?

Ammar Sabilarrohman May 8, 2026 0

After years of grappling with stagnant returns and the post-pandemic "hangover" that plagued the biopharmaceutical sector, a...

Read More Read more about The GLP-1 Paradox: Pharmaceutical R&D Productivity Rebounds, But at What Cost?

The Life and Legacy of Dr. Juliet Daniel: A Pioneer in Cancer Research and Champion of Health Equity

• Patient Advocacy and Support

The Life and Legacy of Dr. Juliet Daniel: A Pioneer in Cancer Research and Champion of Health Equity

Ammar Sabilarrohman September 11, 2025 0

The scientific community, McMaster University, and the global network of cancer researchers are mourning the profound loss...

Read More Read more about The Life and Legacy of Dr. Juliet Daniel: A Pioneer in Cancer Research and Champion of Health Equity